SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-006529
Filing Date
2022-04-28
Accepted
2022-04-28 16:06:44
Documents
5
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A kura_def_14a_2022.htm DEF 14A 1501917
2 GRAPHIC img366175_0.jpg GRAPHIC 2071
3 GRAPHIC img366175_1.jpg GRAPHIC 2573
4 GRAPHIC img366175_2.jpg GRAPHIC 510547
5 GRAPHIC img366175_3.jpg GRAPHIC 165661
  Complete submission text file 0000950170-22-006529.txt   2440636
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37620 | Film No.: 22866502
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences